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Abstract
Background: Prognostic models in reproductive medicine can help to identify subfertile couples who would
benefit from fertility treatment. Expectant management in couples with a good chance of natural conception, i.e.,
tailored expectant management (TEM), prevents unnecessary treatment and is therefore recommended in
international fertility guidelines. However, current implementation is not optimal, leaving room for improvement.
Based on barriers and facilitators for TEM that were recently identified among professionals and subfertile couples,
we have developed a multifaceted implementation strategy. The goal of this study is to assess the effects of this
implementation strategy on the guideline adherence on TEM.
Methods/design: In a cluster randomized trial, 25 clinics and their allied practitioners units will be randomized
between the multifaceted implementation strategy and care as usual. Randomization will be stratified for in vitro
fertilization (IVF) facilities (full licensed, intermediate/no IVF facilities). The effect of the implementation strategy, i.e.,
the percentage guideline adherence on TEM, will be evaluated by pre- and post-randomization data collection.
Furthermore, there will be a process and cost evaluation of the strategy. The implementation strategy will focus on
subfertile couples and their care providers i.e., general practitioners (GPs), fertility doctors, and gynecologists. The
implementation strategy addresses three levels: patient level: education materials in the form of a patient
information leaflet and a website; professional level: audit and feedback, educational outreach visit, communication
training, and access to a digital version of the prognostic model of Hunault on a website; organizational level:
providing a protocol based on the guideline. The primary outcome will be the percentage guideline adherence on
TEM. Additional outcome measures will be treatment-, patient-, and process-related outcome measures.
Discussion: This study will provide evidence about the effectiveness and costs of a multifaceted implementation
strategy to improve guideline adherence on TEM.
Trial registration: www.trialregister.nl NTR3405. This study is sponsored by ZonMW.
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Background
Subfertility is defined as the absence of conception after
one year of unprotected intercourse [1]. It affects ap-
proximately 9% of all couples of reproductive age [2,3].
In approximately 50% of the couples, no major cause is
found after the basic fertility work-up [4]. In those cou-
ples, the chance of natural conception can be calculated
via validated prognostic models [5,6]. If the chance of
natural conception within one year is good, meaning a
probability of 30% or more, expectant management for 6
to 12 months is equally effective as treatment [7]. Be-
cause this expectant management is restricted to couples
with a good prognosis, we have called it tailored expect-
ant management (TEM).
European Society of Reproductive Medicine (ESHRE)
and National Institute of Health and Clinical Excellence
(NICE) guidelines on the management of infertility both
emphasize that couples should not be exposed to un-
necessary risks or ineffective treatments and encourage
that each subfertile couple should receive information
about the estimate of their chance of natural conception
[8,9]. In the Netherlands, the national network guideline
on infertility for gynecologists and general practitioners
(GPs) explicitly recommends the use of prognostic
models and subsequent TEM for couples with unex-
plained or mild infertility [10]. However, at this moment,
implementation of TEM is poor. A recent Dutch multi-
center cohort study showed overtreatment in 36% of the
couples, i.e., 36% of the couples with a good prognosis
eligible for TEM (>30% chance of natural conception in
one year) already started medically assisted reproduction
(MAR) [11].
This overtreatment in subfertile couples is worrisome
for several reasons. First, fertility treatment still leads to a
considerable number of multiple pregnancies, which are
associated with a higher morbidity and mortality in both
mothers and neonates [12]. Second, fertility treatment car-
ries a significant physical and psychological burden and
accompanying productivity loss [13-16]. Third, fertility
treatment and its complications are expensive and put
considerable financial strain on societies where MAR is re-
imbursed or on the subfertile couples in societies where
MAR is not or only partially reimbursed [17].
The first step to improve guideline adherence on TEM
and reduce overtreatment is to gain insight into barriers
and facilitators for implementation of TEM and MAR re-
duction. Subsequently a tailored implementation strategy
can be developed targeting obstacles to change, if neces-
sary at different levels [18,19]. In a previous qualitative
and quantitative study among patients and professionals,
the main barriers among subfertile couples were lack of
confidence in natural conception, perception that expect-
ant management is a waste of time, inappropriate expecta-
tions prior to the first secondary care consultation, and an
overestimation of the success rates of treatment. Both cou-
ples and professionals regarded the lack of patient infor-
mation materials as an important barrier. Among the
professionals, limited knowledge about prognostic models
and limited communication skills to convince the couple,
both leading to a decision in favor of treatment, were rec-
ognized as main barriers. Facilitators experienced by the
professionals were better management of patients’ expec-
tations, local consensus, and the presence of a local proto-
col and local fertility meetings [11,20].
A multifaceted implementation strategy to improve
guideline adherence on TEM has now been developed
based on these data. The aim of this study is to evaluate
effectiveness and costs of this implementation strategy in
a cluster randomized trial.
Methods
Setting
In the Netherlands, subfertile couples are usually referred
by the GP to secondary care. GPs usually perform only
limited basic fertility workup or no workup at all and they
do not prescribe fertility drugs. Secondary and tertiary
care is provided by three different types of fertility clinics
based on the kind of treatment they offer. Initial fertility
assessment, ovulation induction (OI), and intra-uterine in-
semination (IUI) are carried out in all Dutch clinics. In
vitro fertilization (IVF) and intracytoplasmic sperm injec-
tion (ICSI) treatments are only carried out in intermediate
and licensed fertility clinics. Every Dutch citizen has a
basic insurance coverage, which fully reimburses all treat-
ment cycles of OI and IUI, with or without controlled
ovarian hyperstimulation, as well as a maximum of three
IVF or ICSI cycles.
Study design
We propose a cluster randomized trial in 25 clinics and
their allied GP units with an effect, process, and economic
evaluation alongside the trial.
Randomization
The 25 participating clinics and their allied practitioners
units will be randomized between the multifaceted imple-
mentation strategy and care as usual. Randomization will
be stratified for IVF facilities (full licensed, intermediate/
no IVF facilities) and will take place after all clinics have
approval to participate. Randomization will be done by an
independent physician and will be computer-generated.
Results of the randomization will be personally communi-
cated to all participating clinics.
Effectiveness
For the effectiveness, a baseline measurement will be
performed in all participating clinics, including guideline
adherence on TEM, and a range of organizational,
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professional, and patient characteristics (see outcome
measures). Following baseline measurement, the multifa-
ceted implementation strategy will be applied in the inter-
vention clinics. After ten to twelve months of intervention
exposure, the after measurement will be performed again
in all 25 participating clinics.
Process evaluation
A process evaluation, according to Hulscher et al. [21],
will be performed during and after the intervention to
investigate the feasibility of the implementation strategy.
Intervention
The multifaceted implementation strategy, based on a
barrier analysis among professionals and patients, will
focus on three different levels: patient, professional, and
organizational level [20]. The three levels and all associ-
ated tools are successively described here.
Patient level
We will develop patient educational materials in three
different forms, a patient information leaflet, posters,
and a website.
The patient information leaflet will provide general back-
ground information on the fertility work-up procedure,
prognostic factors that influence the chance on spontan-
eous conception, (dis)advantages of expectant manage-
ment, and (dis)advantages of fertility treatment. In every
intervention clinic, posters with information on the prog-
nostic model and expectant management will be placed in
the waiting areas. In the leaflet and on the posters, patients
can find a code which is needed to gain access to the web-
site. There is a different code for each intervention clinic.
The website will give more individualized information by
access to a digital version of the prognostic model of
Hunault [5]. Herewith, patients can calculate their chances
of natural conception within one year and experience the
influence of altering characteristics. It will also provide
additional information on the basic fertility workup, the
chance of natural conception versus the chance of concep-
tion after fertility treatment, (dis)advantages of expectant
management, and (dis)advantages of fertility treatment.
Furthermore, it advises patients what they can do to
optimize their chances of spontaneous conception during
the expectant management period, e.g., information on
intercourse timing and frequency, weight regulation, and
lifestyle. This information will be in accordance with the
information provided in the Dutch national network guide-
line on infertility [10].
This information material will be developed according
to the International Patient Decision Aids Standards
criteria for the dimensions ‘information’ and ‘probabilities’
[22], as well as according to the American Medical Associ-
ation criteria [23].
Professional level (e.g., gynecologists (in training), fertility
doctors, and GPs)
The strategy regarding the professionals contains audit
and feedback, an education outreach visit, supportive
consultation tools, and a video-based communication
training.
The audit and feedback of the current care will consist
of a feedback report based on the results of the baseline
measurement. This feedback will report clinic’s guideline
adherence on TEM in a twelve-month period prior to
the randomization compared with the other participat-
ing clinics. It will give insight in how they are adhering
to the guideline concerning the policy for couples with
unexplained or mild infertility, e.g., use of prognostic
models and subsequent TEM in case the prognosis is
good. Furthermore, the report will provide feedback on
patient-related measures like general experiences with
fertility care, specific experiences with the prognostic
model and TEM, quality of life, and trust in their phys-
ician [ref].
In addition to this audit and feedback, an educational
outreach visit will take place with fertility doctors and gy-
necologists (in training), in which background information
about how and when to use the prognostic model of
Hunault, and subsequent TEM will be given and in which
the results of the baseline measurement and local barriers
will be discussed. The result of this visit will be an individ-
ualized action plan per clinic.
The supportive consultation tools are developed
containing a digital version of the prognostic model of
Hunault on a website and we will provide professionals
with a summary of the guideline on TEM in the form of a
pocket card.
Finally, a video-based training strategy will be provided
to improve the communication techniques to counsel the
patients on their chance of spontaneous conception versus
conception after treatment, the (dis)advantages of expect-
ant management versus fertility treatment, and on the rea-
son for TEM (i.e., making clear it is not a waste of time).
Consistent with functional models of medical communica-
tion described in the field [24], the LEAPS Framework,
a pneumonic for Listen, Educate, Assess, Partner and
Support will be used to develop the intervention [25].
Organizational level (GP units and fertility clinics)
During the educational outreach visits an example of an
up-to-date local protocol will be offered to the fertility
clinics that do not already have an updated protocol
available. This local protocol will be based on the Dutch
network guideline on infertility, and it will focus on the
initial fertility assessment (diagnostics), identification of
patients with mild or unexplained infertility, the use of
the prognostic model of Hunault, and TEM [10]. The
clinics can adjust this protocol to their own lay out and
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they can distribute it either in the form of a hard copy
or digital copy, depending on the preference of the
professionals.
Furthermore, we will provide the GPs allied to the
intervention clinics with feedback on their referral behavior,
e.g., were patients referred according to the guideline
recommendations.
Study population/participants
To include a representative patient group, we will select
potential participating couples retrospectively in each
clinic by means of the clinics’ financial registration data-
base (Diagnosis Treatment Combination code). In this
nationwide registration system, patients undergoing diag-
nostics or treatment for infertility are identified with a spe-
cific fertility code (F-code). For the baseline measurement,
we will invite couples that were given the code for new
fertility patients (F-11) between February 2011 to March
2012 to participate in this study. For the after measure-
ment, we will invite the couples that were given the F-11
code during the ten- to twelve-month intervention period.
We will invite couples to participate by giving their per-
mission for a medical record study and filling out a
questionnaire.
The couples are eligible to participate when they have
been diagnosed with unexplained or mild infertility, have
a good prognosis (>30%) according to Hunault’s predic-
tion model, did not have previous fertility treatment,
and the female age is between 18 and 38 years. Couples
with bilateral tubal pathology, severe male factor, or
anovulation are not eligible to participate.
Sample size
The expected adherence to TEM in the control arm is
estimated based on previous studies at 60% [11]. To in-
crease this to 80% with an intra-class correlation (ICC)
of 0.1, alpha at 5%, comparing two strategies, we esti-
mate that with 25 clusters we would need a total sample
size of 450 patients. This means we need to include
15 to 20 patients per clinic in the baseline as well as in
the after measurement.
Outcome measures
Primary outcome effectiveness
The primary outcome measure of the proposed study
for effectiveness will be the guideline adherence rate on
TEM: the percentage of couples that are eligible for
TEM (couples with mild or unexplained infertility with a
prognosis of >30% of natural conception within one
year) who actually agree upon the expectant manage-
ment period of at least six months after the initial fertil-
ity assessment is concluded.
Secondary outcomes effectiveness
1. Treatment-related measures: time to the start of
fertility treatment and the number and types of
fertility treatments that the couples received.
2. Treatment outcome-related measures: (ongoing)
pregnancy rate, miscarriage, extra uterine gravidity,
multiple pregnancy rate, and time to pregnancy.
3. Patient-related outcome measures : general
experiences with fertility care such as information
provision, respect for patients’ values and
accessibility of care (to be measured with Patient
Centeredness Questionnaire Infertility) [26], specific
experiences with the prognostic model and TEM,
quality of life (estimated by FertiQoL)[27], and trust in
physician (measured by Wake Forest Trust Scale) [28].
4. Process related measures: percentage transition of
patients to another fertility center.
5. Background characteristics that could influence
guideline adherence (e.g., age, referral status, type of
infertility, duration and cause of infertility).
Outcomes process evaluation
1. Actual ‘exposure’ of patients and physicians to the
different elements of the implementation strategy.
2. How frequently the website has been visited by
patients and physicians.
3. Experiences of patients and physicians with the
different elements of the implementation strategy.
Data collection
Effectiveness
Data collection will be performed from medical records
and a patient questionnaire.
Data abstraction from medical records will be performed
using a standardized audit form. We will collect the back-
ground characteristics, treatment related measures, treat-
ment outcome-related measures, and process-related
measures.
The questionnaire will be divided into four parts. The
first part consists of background questions (e.g., highest
educational level, country of birth). The second part
regards the patients’ experience with the prognostic
model and TEM as well as the patients’ trust in both
the GP as well as the fertility doctor/gynecologist. The
third part is the Patient-Centeredness Questionnaire-
Infertility, a validated instrument measuring patient-
centeredness of fertility care by asking about patients’
experiences with care. The last part is the FertiQol
questionnaire, We will only use the Core module, which
involves questions about mind-body, emotional, rela-
tional, and social aspects.
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Process evaluation
For the process evaluation, we will approach the local in-
vestigator during the intervention period to provide us
with feedback about the implementation strategy. We will
also keep track of how often the website is visited by log-
ging data. At the end of the ten- to twelve-month inter-
vention period, we will evaluate the strategy by means of a
professional questionnaire and an addendum to the pa-
tients’ questionnaire in the after measurement.
Data analysis
To analyze the effectiveness of the implementation strat-
egy, descriptive statistics and multilevel analysis will be
used. The statistical analysis will be performed using
SPSS version 16.0 for Windows.
The main outcome, the difference in baseline and after-
measurement scores in guideline adherence on TEM, be-
tween the intervention and control group will be analyzed
with the chi-square test.
Descriptive analysis will be used to assess the difference
in treatment-related, treatment outcome-related, and
patient-related measurements between the intervention
and control group. Furthermore, time to pregnancy and
time to start fertility treatment will be analyzed using
Kaplan Meier analysis with log-rank test. Univariate and
subsequent multivariate logistic and Cox regression ana-
lyses will be used to analyze the relative contribution of
the implementation strategy versus other predictive fac-
tors for guideline adherence on TEM.
Economic evaluation
We plan an economic evaluation alongside the clinical
trial to investigate the cost-effectiveness of the multifa-
ceted implementation strategy to improve guideline adher-
ence on TEM. This economic evaluation compares the
multifaceted implementation strategy to usual care and is
done from a societal perspective. A distinction will be
made between costs of the development and introduction
of the implementation strategy and the costs of maintaining
the implementation strategy. The input of resources is
assessed by collecting volumes of consumed resources (e.g.,
medical interventions like number IUI and IVF cycles and
treatment related outcomes like ovarian hyperstimulation
syndrome and multiple pregnancies) and multiplied by
reported or guideline prices according to Oostenbrink [29].
To assess non-medical and indirect costs, we will build on
the data collection and cost calculation frameworks from
previous cost studies on IUI and IVF [30,31]. The incre-
mental costs, expressed as costs/percentage guideline ad-
herence to TEM, are determined by the differences in
resource consumption and adherence rates between the
intervention group and the control group. Robustness of
the results (costs and health outcomes) for various assump-
tions and parameters estimates will be explored in
sensitivity analyses and visualized in incremental cost-
effectiveness ratio graphs and cost-effectiveness acceptabil-
ity curves.
Trial status
We are currently performing the baseline measurement
in all participating clinics.
Discussion
This cluster RCT will compare a multifaceted implemen-
tation strategy to usual care on improving guideline adher-
ence to TEM. If TEM is applied more frequently, it will
reduce the number of performed IUI, IVF, and ICSI cycles,
the incidence of treatment related complications (e.g.,
ovarian hyperstimulation syndrome and multiple pregnan-
cies), and we expect it to reduce the physical and psycho-
logical burden. As a consequence, the costs for fertility
treatment will decrease.
Many different interventions are available to implement
guidelines, either focusing on professionals, patients,
teams or organizational factors, and with variable effects.
A systematic review on interventions to improve guideline
implementation showed that interventions tailored to pro-
spectively identified barriers are more likely to improve
professionals practice than only dissemination of guide-
lines [32]. The strategy that we developed is tailored to the
recently identified barriers and facilitators for TEM, thus
more likely to improve professionals practice, in this case,
adherence to the guideline. Moreover, in general, com-
bined interventions are believed to be more effective than
single interventions [32]. Therefore, to increase the poten-
tial effectiveness of our implementation strategy, we devel-
oped a multifaceted intervention that targets the specific
barriers for TEM at different levels.
For the specific interventions that will be used in the
multifaceted implementation strategy, the review showed
that audit and feedback and educational outreach visits
can be effective (small to moderate) [32-34] and patient-
directed interventions such as educational materials may
result in moderate to large effects to increase adherence to
recommended care [32]. Moreover, it has been proven
that subfertile patients appreciate education and improved
knowledge, and it has also been demonstrated to influence
their healthcare decisions [35,36]. In a systematic review,
only the effect of paper version materials was studied.
However, because surveys have shown that online health
information retrieval and eHealth activities are becoming
increasingly common, especially within young and highly
educated subfertile patients [37-40], we decided to offer
the patient information materials in both paper and digital
forms (i.e., website and application). By doing so, and thus
tailoring the patient-directed intervention to the infertility
population, we hope to increase the effect of this interven-
tion even more.
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Aside from the multifaceted and barrier tailored aspects
of the strategy, this study has several more strengths.
First, the number of participating clinics is a great
strength of this study. One-quarter of all Dutch clinics
from all over the country participate in this study, ensur-
ing the representativeness of the Dutch infertility popula-
tion as well as the professionals who provide fertility care.
Second, the process evaluation provides us with more
information on the effectiveness and usefulness of the
different interventions used in the strategy and not only
of the multifaceted implementation strategy as a whole.
We know that the multifaceted aspect of the interven-
tion does not necessarily make the intervention more ef-
fective, therefore we need to assess the effectiveness of
each individual intervention separately as well [36]. This
is of great value for further implementation research and
development of implementation strategies. Furthermore,
if the multifaceted implementation strategy proves to be
effective, it could also be generalized to improve imple-
mentation of other guidelines.
Third, the cost evaluation that will take place is very
important from a societal aspect. Healthcare is becoming
increasingly expensive, and cost reduction is a very im-
portant and common topic in most governments and
healthcare institutes. This economic evaluation will pro-
vide further information on how we can reduce costs in
healthcare by following the current and already existing
guidelines for best practice and care.
A possible limitation of the study is the chance of con-
tamination of the GPs between the intervention and
control group. GPs can refer patients to more than one
clinic; this makes it possible that a GP who is allied to
an intervention clinic can also refer patients to a control
clinic. However, we think that the occurrence of actual
contamination will be very small because the participat-
ing clinics are very well spread over the country. In case
contamination of GPs does occur, we expect the effect
on the outcome to be very small or even undetectable
because the multifaceted intervention strategy is mostly
targeted at the secondary and tertiary care.
In summary, the main contribution of this study is
that it seeks to identify the most effective strategy for
implementing the guideline on TEM in subfertile cou-
ples. Ensuring the appropriate uptake of guideline rec-
ommendations by both professionals and patients will
improve the care for these patients.
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